- Home
- OM vs VOR Comparison
OM vs VOR Comparison
Compare OM & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OM
- VOR
- Stock Information
- Founded
- OM 2003
- VOR 2015
- Country
- OM United States
- VOR United States
- Employees
- OM N/A
- VOR N/A
- Industry
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- OM Health Care
- VOR Health Care
- Exchange
- OM Nasdaq
- VOR Nasdaq
- Market Cap
- OM 224.0M
- VOR 207.1M
- IPO Year
- OM 2020
- VOR 2021
- Fundamental
- Price
- OM $14.83
- VOR $27.49
- Analyst Decision
- OM Hold
- VOR Buy
- Analyst Count
- OM 1
- VOR 6
- Target Price
- OM $22.00
- VOR $85.33
- AVG Volume (30 Days)
- OM 312.0K
- VOR 511.2K
- Earning Date
- OM 11-10-2025
- VOR 11-07-2025
- Dividend Yield
- OM N/A
- VOR N/A
- EPS Growth
- OM N/A
- VOR N/A
- EPS
- OM N/A
- VOR N/A
- Revenue
- OM $119,304,000.00
- VOR N/A
- Revenue This Year
- OM $12.46
- VOR N/A
- Revenue Next Year
- OM $10.51
- VOR N/A
- P/E Ratio
- OM N/A
- VOR N/A
- Revenue Growth
- OM 2.47
- VOR N/A
- 52 Week Low
- OM $5.85
- VOR $2.62
- 52 Week High
- OM $25.35
- VOR $65.80
- Technical
- Relative Strength Index (RSI)
- OM 54.54
- VOR 49.87
- Support Level
- OM $12.66
- VOR $25.62
- Resistance Level
- OM $15.94
- VOR $28.31
- Average True Range (ATR)
- OM 1.21
- VOR 2.22
- MACD
- OM 0.14
- VOR -1.61
- Stochastic Oscillator
- OM 74.03
- VOR 22.37
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.